vated latent virus or arises from exogenous infections introduced via the donor kidney or blood. Warrell and her colleagues2 showed in a prospective study that most primary infections with cytomegalovirus occurred within the first two months after grafting and that the likely source of these infections was the donor kidney. Secondary infection in the seropositive patients occurred independently of the antibody status of the kidney donor.
In 1971 a new virus, a human polyomavirus, was isolated from the urine of a renal transplant recipient and named BK virus (the initials of the patient).3 Subsequent work in England with BK virus showed that 70% of renal transplant recipients were seropositive at the time of the transplant operation and that just over half of them had serological evidence of an active infection after transplant.4 In the original patient BK and in four other patients in Study of human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients a later investigation, this infection was associated with ureteric stenosis and recognised because of the large number of inclusion-bearing cells seen in the urine.5 6 An antigenically distinct but similar polyomavirus, JC virus, was also isolated in 1971 from the brain of a patient with Hodgkin's disease and the rare demyelinating disease progressive multifocal leucoencephalopathy (PML).7 PML is uncommon and is seen as a late complication in patients with altered immunity subsequent to diseases such as chronic lymphocytic leukaemia, Hodgkin's disease, lymphosarcoma and sarcoidosis. Ten cases of PML have been reported in renal transplant recipients.8'0 JC virus has been identified in 44 cases of PML and is considered the main agent of this disease."I Silent infection with JC virus is common in children and adults, unassociated with any neurological disease, and the virus has been found in the urine of renal transplant recipients'2 13 and also pregnant women.'4 A prospective study of renal transplant recipients was started in 1977 in an attempt to determine: (a) whether primary or secondary infections with BK and JC viruses were associated with any clinical illness or effect on renal function; and (b) the time of these infections in relation to the transplant operation. The patients were also studied for evidence of cytomegalovirus infection in order to be able to eliminate any possible effects due to this virus.
Material and methods

STUDY GROUP
During the three year period from December 1977 until September 1980, 65 patients received kidney transplants and initially entered the study. Thirteen of them, however, suffered acute rejection and transplant nephrectomy within four weeks of the transplant operation; three patients died within the same period; and one patient returned to Greece and was not followed further. These 17 patients were excluded from the investigation.
The study group therefore consisted of 48 patients, with a mean age of 37 years (range 11-55 years). Twenty nine patients were male and 19 female. Forty four patients were recipients of a first kidney transplant and four were recipients of a second graft. Only two patients were given kidneys from living related donors, whereas 46 received cadaver kidneys. Serial serum samples were obtained from all patients. These were taken immediately before the transplant operation, twice weekly during the first few weeks, then at increasing intervals of two weeks, one month, and three months, depending on when they attended the outpatients department or were readmitted to hospital. Urine samples for cytological examination were obtained as described below. The patients were followed from two to 46 months ( 
Electron microscopy
Selected urine samples were examined by electron microscopy. Three millilitre volumes were centrifuged at 20 000 rpm for 1 h and the resulting pellets were diluted in distilled water, mixed with 0-05% bovine plasma albumin, and negatively stained with 3% phosphotungstic acid at pH 6.3. A drop was applied to a 400 mesh formvar-carboncoated grid and examined at a magnification of X60 000 in an AEI EM 6B electron microscope.
Virus isolation
The urine samples were inoculated into human fetal brain cells, human embryo kidney cells, and human embryo lung fibroblast cells for the isolation of JC virus, BK virus, and cytomegalovirus respectively as described previously.'4 A minimum total incubation time of three months was achieved before cultures were considered negative for BK and JC viruses. The polyomaviruses were identified by the haemagglutination inhibition method using specific antisera.
Results
CYTOLOGY
During the study 3497 urine specimens were examined cytologically and inclusion-bearing cells were seen in 327 (9%). Twenty one (44%) of the 48 patients were identified as excretors.
The inclusion-bearing cells were easily identified in the cytological preparations. Invariably they were larger than normal urothelial cells. The nuclei were mainly of three types; those with an opaque ground glass appearance; those with only the nuclear border of condensed chromatin remaining; and, rarely, those with the classic "owl's eye" appearance with the hyperchromatic inclusion centrally placed.
VIROLOGY
An active polyomavirus infection, diagnosed serologically or by electron microscopy or virus isolation, or Urine samples were examined from 14 of the 19 patients and infection was confirmed in eight. Polyomavirus particles were seen in the urine of seven patients and BK virus was isolated from five and JC virus from one. One other patient was excreting BK virus.
Thirteen urine samples were examined from the six patients excreting BK virus. The virus was present in the urine between five and eight weeks after the transplant operation in four of the six excretors; between 12 and 17 weeks in one; and at 34 weeks in another. In all six patients BK virus was first isolated at a time when the BK virus antibody titre was low. Subsequently there was a greater than 100 fold Only two patients therefore may have had a clinical response to the secondary BK virus infection. One of them experienced fever, malaise, and vomiting in the second month after transplantation and the other, patient F, developed ureteric stenosis. Details of the laboratory findings in the latter case are shown in Fig. 2 . In 1977 patient F received a first renal transplant and was treated for early rejection at eight days with methyl prednisolone. Five weeks later virus inclusion-bearing cells were seen in the urine. At this time his renal function deteriorated and he was again treated with methyl prednisolone for possible rejection. Excretory urography showed that the donor ureter was partially obstructed and a renal biopsy showed no evidence of acute rejection. In view of this finding and because of the concurrent infection with BK virus, further acute rejection therapy was withheld. The BK virus antibody concentrations rose sharply, the inclusion-bearing cells disappeared from the urine, and his renal function recovered. The patient remained well with a functioning graft four years after the operation. At the same time as the BK virus infection, his cytomegalovirus antibody titre rose from 64 to 512; four weeks later he developed JC virus antibody (Fig. 2) 16 weeks and 10 months after transplantation. JC virus was isolated from the former urine but not from the latter, probably because the virus particles had been coated with antibody.
Twelve of the 26 seropositive patients (46%) had eight fold or greater increases in JC virus antibody, suggesting a secondary infection, but six of them also had rises in antibody to BK virus and in most cases this was the major response. Nevertheless, in two patients known to be excreting BK virus both BK and JC virus specific IgM was present in their serum. It was not possible to be sure in those patients with serological evidence of infection with both viruses whether these were dual infections or anamnestic responses.
Seventeen urine samples were examined from seven of the 12 patients. Polyomavirus particles were seen by electron microscopy in the urine of five patients. JC virus was isolated on two occasions from one of them at 14 months and 31 months after transplantation and BK virus from three. An unidentified polyomavirus was isolated 16 months after transplantation from the other patient; this Study of human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients virus was probably JC virus from its restricted growth pattern in cell culture.
About one third of the transplant recipients studied were infected with JC virus after transplantation and inclusion-bearing cells were found in 13 of these 17 patients.
Time of JC virus infection related to the transplant operation and the clinical response One of the patients (patient B) with a primary infection with JC virus had evidence of infection 10 days after a second transplant operation (Table 3) . Patient B, a child of 12 years, had not seroconverted after the first transplant operation and he remained seronegative to both JC and BK viruses for two years (Fig. 1) . During this period the original renal disease recurred and renal function deteriorated and he was managed by haemodialysis. He received an increased dose of azathioprine before the second transplant operation and six days after transplantation was given methyl prednisolone because of reduced renal function. At 10 days he had a mild fever and developed antibody to both JC and BK viruses. After two months, antibody to both viruses declined and remained low for the next 10 weeks. During this interval inclusion-bearing cells were present in the urine and JC virus isolated. Eighteen weeks after the operation there was a second substantial rise in antibody titre to both viruses (Fig. 1 ) and the JC virus antibody concentrations remained raised until his death 18 months after the second renal transplant. Specific IgM antibodies to both BK and JC viruses were present and a rise followed by a fall and then subsequent rise was shown similar to the IgG response.
The other four primary infections occurred between 15 and 16 weeks after the operation (two cases) and at 11 and 12 months ( Primary infections Nineteen of the 48 patients (40%) had no cytomegalovirus antibody before the transplant operation. Six (32%) of these 19 seronegative cases experienced a primary infection (Table 1) . Five of the infections occurred between four and seven weeks after transplantation and one was at 10 weeks. Unlike the primary infection with BK and JC viruses all six patients had symptoms related to the cytomegalovirus virus infection and none of them was experiencing a concurrent polyomavirus infection. Three of the six patients were seriously ill with fever and pneumonia, two also had a pancreatitis, and one patient died from the infection. Nevertheless, four of the five surviving patients made a good recovery and had functioning grafts at the end of the study period.
Secondary infections
Twenty four (83%) of the 29 seropositive patients had secondary infections with cytomegalovirus (Table 1 ). In 17 of the 24 patients (71%) the infection occurred betweeen four and eight weeks after transplantation. In five it was between nine and 12 weeks, and in only two patients (8%) was there a late infection at eight and 17 months.
Thirteen of the patients had symptoms possibly related to the cytomegalovirus infection. Twelve developed fever and in five this was accompanied by respiratory symptoms. One patient had malaise and vomiting. Although six of the 13 patients also had concurrent infection with a polyomavirus it was thought unlikely that this virus was responsible for the symptoms encountered. 584 BK and JC virus infection related to renal function and graft survival Renal function was reduced at the time of infection in eight of the 21 patients known to have had a BK virus infection after transplantation. In three of the patients the impaired renal function was the result of acute or acute on chronic rejection unrelated to the BK virus infection and these three patients eventually had transplant nephrectomies. One other patient had progressive deterioration of renal function and transplant nephrectomy because of the recurrence of the original renal disease. In four patients, however, the reduced renal function coincided with the BK virus infection and in one patient was associated with ureteric stenosis. Renal function improved without treatment (except decreasing immunosuppression in one case) in the four patients and all had functioning renal graft at the end of the study.
Only four of the 19 patients with either a primary or secondary JC virus infection after transplantation also had impaired renal function at the time of the infection. In one this occurred eight days after the transplant operation and was transient. Afterwards the renal output in this patient was satisfactory for eight months until the original disease recurred. In the second patient there were no rejection episodes and renal function was good until the JC virus infection four weeks after transplant. Subsequently the function did not recover and continued to deteriorate.
Two other patients had impaired renal function five weeks and 12 weeks after the transplant operation. Both were treated with methyl prednisolone and one developed viral pericarditis with pericardial effusion. Retrospectively they were shown to have had secondary JC virus infection at this time. Renal function recovered quickly in both patients and the grafted kidneys continued to function well.
Discussion
Nearly two thirds of the patients in this study group had either a primary or a secondary infection with one or both polyomaviruses BK and JC. The polyomavirus infections were as frequent as those associated with cytomegalovirus, which are known to be common after transplantation.'5 The incidence of polyomavirus infection after renal transplant was greater than that reported in 1980 by Hogan et al in the USA, where just half of the 61 patients investigated had evidence of an active infection. '3 Cytological examination of the urine proved to be a useful technique in identifying polyomavirus excretors. Twenty one of the 31 patients (68%) identified serologically as infected with BK or JC Gardner, MacKenzie, Smith, Porter virus, or both, were found to be excreting inclusion-bearing cells, whereas none of the 11 patients with cytomegalovirus infection only were excreting these cells.
Most of the transplant patients in our study had BK virus antibodies before the transplant operation. Therefore, few were at risk of a primary infection. Nearly half of the patients, however, had no antibody to either JC virus or cytomegalovirus, and of these five (23%) had primary infections with JC virus and six (32%) with cytomegalovirus. Of the seropositive patients in the present study the rate of secondary infections with BK and JC viruses were 45% and 46% respectively. The rate of secondary cytomegalovirus infections in the patients was 83%, an incidence similar to that found by other workers.'5
An increase in antibody titre to both BK and JC viruses occurred in seven patients. In four patients the rise was observed at different times after the transplant operation, but in three patients the antibody responses were identical in timing and concentrations as can be seen in patient B (Fig. 1) . Similar responses were seen in two patients reported previously.'2 When the antibody responses occurred simultaneously it was difficult to assess whether both viruses were active at the same time or one response was anamnestic. One of the authors (SDG) has isolated both BK and JC viruses from the urine of a bone marrow transplant recipient,'6 but usually only one virus is isolated. Hogan and his colleagues,'7 using immunofluoresence to stain exfoliated inclusion-bearing cells, have shown both BK and JC virus antigens in the same urine sample in five patients. This technique is probably the most sensitive one for confirming mixed infections.
Most of the previous reports of polyomavirus infections in kidney transplant recipients have considered only BK virus infections and have not included serological studies with JC virus. The reported incidence of BK virus infections after transplantation deduced from serological observations has ranged from 12% to 38%.4 3 118-20 Evidence of polyomavirus excretion confirmed by electron microscopy or by virus isolation has varied from 0% to 44%.4 12 18 21 The variation in these observations may be because serial sera were not examined and many of the patients studied were not investigated from before the transplant operation. Also in many instances urines may not have been taken at the peak time for virus excretion.
In the present investigation about half of the secondary polyomavirus infections occurred between four and eight weeks after transplantation compared with 71% of the cytomegalovirus infections. Late 
